Covidien's robust health in dire times is down to "sticking to the basics"
This article was originally published in Clinica
In the fourth instalment of Clinica's Industry Leaders series, Peter Wehrly, group president of Covidien's respiratory and vascular businesses, discusses how the company has been weathering the economic storm and its strategy for keeping ahead of the game. Tina Tan reports
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.